Leqselvi
Deuruxolitinib phosphate · Sun Pharmaceutical Industries, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Leqselvi ingredients
| Active ingredient | Strength |
|---|---|
| Deuruxolitinib Phosphate | 8 mg/1 |
What Leqselvi is used for
Leqselvi is a cancer medicine (janus kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Leqselvi
- Generic name
- Deuruxolitinib phosphate
- Made by
- Sun Pharmaceutical Industries, Inc.
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Janus Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA217900
- On the US market since
- 2025
Official information
- MedlinePlus drug information (search for Deuruxolitinib phosphate)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Leqselvi?
Leqselvi (Deuruxolitinib phosphate) is a cancer medicine made by Sun Pharmaceutical Industries, Inc., approved by the US FDA.
What are the ingredients of Leqselvi?
Leqselvi contains Deuruxolitinib Phosphate (8 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA